Latest Biotech News

Allswell raised a $7 million seed round to expand its LGBTQ+-focused behavioral health platform, led by Rethink Impact with participation from Magnify Ventures, Ulu Ventures and Hopelab Ventures....

A review in Immunity & Inflammation lays out the evolving case for in vivo CAR-T—shifting from multi-week, ex vivo manufacturing toward engineering T cells inside the patient. The article, led by...

MD Anderson researchers reported that success with off-the-shelf CAR T therapies depends on two measurable factors: pre-existing immune rejection and the intrinsic fitness of donor-derived CAR T...

A commentary published by MedCity News argues that the world’s antibiotic scarcity is not primarily a scientific discovery problem—rather, it is an access and market-entry failure that prevents...

Multiple studies highlighted new imaging-based approaches to identify patients at risk earlier or more precisely across oncology. One analysis in the EQUIP study reported that a next-generation...

A randomized trial in Nature Communications reported that the oral CDK7 inhibitor samuraciclib plus fulvestrant improved clinical benefit rates in women with advanced HR-positive, HER2-negative...

A randomized trial using in situ viral imaging and mass spectrometry reported that first-line dolutegravir/lamivudine therapy reaches HIV-1 infected cells within lymph node tissue and coincides...

Researchers in Beijing reported that soluble PD-1 (sPD-1) measured the day before liver transplantation can flag recurrence risk in patients who received immune checkpoint inhibitors before...

UPMC Enterprises invested in VeloSource to expand the AI-enabled clinician staffing platform. The move targets workforce operations, with UPMC planning further development of the technology for...

A global scoping review reported that vaccination programs measurably reduce antibiotic consumption and drug-resistant infections, positioning immunization as a lever for antimicrobial...

A study from Insilico Medicine said it will present first-in-human data for ISM6331, an AI-designed pan-TEAD inhibitor, at ESMO 2026. The TEAD pathway is implicated in multiple cancers through...

A randomized trial combining in situ viral imaging and mass spectrometry reported that standard first-line dolutegravir/lamivudine penetrates lymph node reservoirs, coinciding with a rapid decline...

MD Anderson reported new data on why off-the-shelf CAR T therapies succeed for some patients but fail for others. The study found that pre-existing immune rejection and intrinsic donor CAR T cell...

A study reported in the immunotherapy space suggested not all immune checkpoint inhibitor side effects are equal for survival. The work challenges the common clinical interpretation that adverse...

A two-year randomized controlled trial in Shanghai found that stronger atropine eye drops meaningfully slowed severe myopia progression in children with high myopia. The study evaluated nightly...

Patient-derived microtumors grown from tiny needle biopsy samples were reported to predict which breast cancer drugs would work, with results aligning with actual clinical outcomes in a short 2–3...

A study described neutrophils’ role in liver cancer immune evasion by identifying NET-linked gene scores that point to candidate mechanisms. The work frames cancer escape as not just T-cell...

An interpretable machine learning model was reported to predict 7-, 14-, and 28-day mortality in sepsis-associated liver injury, outperforming modified SOFA and MELD-Na in an independent Chinese...

A retrospective study reported that radiotherapy for cervical cancer may trigger herpes virus reactivation, with reactivation observed in a subset of women and exclusively among cervical cancer...

A retrospective study of geriatric diabetic foot patients reported that a simple score based on preoperative hemoglobin, platelet count, and albumin strongly discriminated 24-month mortality after...